Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

ClinicalTrials.gov ID: NCT06662539

Public ClinicalTrials.gov record NCT06662539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities

Study identification

NCT ID
NCT06662539
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zealand Pharma
Industry
Enrollment
493 participants

Conditions and interventions

Conditions

Interventions

  • Petrelintide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2024
Primary completion
Sep 29, 2025
Completion
Mar 6, 2026
Last update posted
Mar 22, 2026

2024 – 2026

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Excel Medical Clinical Trials, LLC Boca Raton Florida 33434
Innovative Research of West Florida, Inc. Clearwater Florida 33756
Century Research LLC Miami Florida 33155
Clinical Research Center of Florida Pompano Beach Florida 33060-6977
Palm Beach Research Center West Palm Beach Florida 33409
Great Lakes Clinical Trials LLC dba Flourish Research Chicago Illinois 60640
AMR Wichita East Wichita Kansas 67226
Alliance For Multispecialty Research, LLC Lexington Kentucky 40509
Mercury Street Medical Group, PLLC Butte Montana 59701
CHEAR Center LLC The Bronx New York 10455
Javara Inc Charlotte North Carolina 28210
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408
Lucas Research, Inc. New Bern North Carolina 28562
AMR Norman Norman Oklahoma 73069
Altoona Center for Clinical Research - Research Duncansville Pennsylvania 16635
Alliance for Multispecialty Research Knoxville Tennessee 37909
Clinical Trials of Texas, LLC., dba Flourish Research San Antonio Texas 78229
Manaasas Clinical Research Center Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06662539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06662539 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →